From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: PYC

Search articles by EPIC code

Physiomics – “Collaboration with The University of Sheffield” announcement. RNS Reach ramptastic?

Describing itself as “a leading mathematical modelling company” in drug development and personalised medicine, Physiomics (PYC) states that it is now “delighted to have been selected by The University of Sheffield to support this highly innovative research program with our analytical and modelling capabilities”. So what’s the detail which has helped the shares up from 2.15p to 2.30p today?

Physiomics – ‘Collaborative Services Agreement’ follows conference participation announcement. Attempted ramptastic?

Mathematical modelling drug development consultancy Physiomics (PYC) has announced a Collaborative Services Agreement, which it states “will expand the scope of our core consulting business to discovery stage projects and improve our access to clients focused on earlier stages of drug development”. So what of a share price currently up to 3p?

Physiomics – “signs of returning to normality”, so why the share price fall?...

Physiomics (PYC) has updated including “we already see that clinical trials and patient recruitment are showing signs of returning to normality” and “the company's cash position remains strong, and it is estimated that on 30 June 2021 its net asset position will be c.£1.1m, the majority of which is cash”. Why then have the shares currently responded to 5.95p, more than 7% lower?...

Page 1 of 2 (14 articles)
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments